セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/07 | 2,911 | 2,920 | 2,809 | 2,832 | -73 | -2.5% | 160,300 |
| 2023/04/06 | 2,939 | 2,960 | 2,893 | 2,905 | -64 | -2.2% | 110,900 |
| 2023/04/05 | 3,060 | 3,060 | 2,961 | 2,969 | -121 | -3.9% | 215,600 |
| 2023/04/04 | 3,140 | 3,140 | 3,065 | 3,090 | -70 | -2.2% | 131,200 |
| 2023/04/03 | 3,155 | 3,230 | 3,125 | 3,160 | +60 | +1.9% | 99,800 |
| 2023/03/31 | 3,170 | 3,195 | 3,095 | 3,100 | -55 | -1.7% | 96,400 |
| 2023/03/30 | 3,140 | 3,170 | 3,090 | 3,155 | -10 | -0.3% | 99,700 |
| 2023/03/29 | 3,185 | 3,230 | 3,140 | 3,165 | -55 | -1.7% | 106,900 |
| 2023/03/28 | 3,260 | 3,285 | 3,190 | 3,220 | -50 | -1.5% | 55,800 |
| 2023/03/27 | 3,275 | 3,300 | 3,245 | 3,270 | -65 | -1.9% | 56,000 |
| 2023/03/24 | 3,400 | 3,400 | 3,265 | 3,335 | -40 | -1.2% | 124,800 |
| 2023/03/23 | 3,185 | 3,395 | 3,165 | 3,375 | +175 | +5.5% | 142,800 |
| 2023/03/22 | 3,275 | 3,280 | 3,175 | 3,200 | -5 | -0.2% | 95,600 |
| 2023/03/20 | 3,545 | 3,575 | 3,200 | 3,205 | -290 | -8.3% | 171,700 |
| 2023/03/17 | 3,300 | 3,550 | 3,300 | 3,495 | +250 | +7.7% | 255,600 |
| 2023/03/16 | 3,150 | 3,270 | 3,050 | 3,245 | -15 | -0.5% | 287,300 |
| 2023/03/15 | 3,530 | 3,660 | 3,235 | 3,260 | -160 | -4.7% | 703,200 |
| 2023/03/14 | 3,510 | 3,545 | 3,400 | 3,420 | -80 | -2.3% | 264,000 |
| 2023/03/13 | 3,355 | 3,500 | 3,355 | 3,500 | +80 | +2.3% | 152,300 |
| 2023/03/10 | 3,500 | 3,530 | 3,400 | 3,420 | -75 | -2.1% | 113,400 |
| 2023/03/09 | 3,495 | 3,515 | 3,440 | 3,495 | ±0 | ±0% | 104,200 |
| 2023/03/08 | 3,605 | 3,615 | 3,485 | 3,495 | -135 | -3.7% | 196,100 |
| 2023/03/07 | 3,685 | 3,710 | 3,620 | 3,630 | -20 | -0.5% | 65,300 |
| 2023/03/06 | 3,680 | 3,740 | 3,650 | 3,650 | +30 | +0.8% | 110,600 |
| 2023/03/03 | 3,560 | 3,640 | 3,560 | 3,620 | +60 | +1.7% | 78,000 |
| 2023/03/02 | 3,580 | 3,590 | 3,505 | 3,560 | -55 | -1.5% | 99,700 |
| 2023/03/01 | 3,675 | 3,675 | 3,575 | 3,615 | -90 | -2.4% | 141,500 |
| 2023/02/28 | 3,600 | 3,740 | 3,600 | 3,705 | +115 | +3.2% | 127,500 |
| 2023/02/27 | 3,560 | 3,640 | 3,545 | 3,590 | -15 | -0.4% | 87,400 |
| 2023/02/24 | 3,560 | 3,620 | 3,460 | 3,605 | +45 | +1.3% | 94,100 |
| 2023/02/22 | 3,535 | 3,580 | 3,515 | 3,560 | -40 | -1.1% | 66,400 |
| 2023/02/21 | 3,685 | 3,685 | 3,585 | 3,600 | -60 | -1.6% | 68,500 |
| 2023/02/20 | 3,595 | 3,675 | 3,570 | 3,660 | +110 | +3.1% | 97,200 |
| 2023/02/17 | 3,535 | 3,610 | 3,520 | 3,550 | -15 | -0.4% | 50,300 |
| 2023/02/16 | 3,500 | 3,590 | 3,470 | 3,565 | +65 | +1.9% | 53,500 |
| 2023/02/15 | 3,510 | 3,555 | 3,455 | 3,500 | ±0 | ±0% | 70,200 |
| 2023/02/14 | 3,590 | 3,605 | 3,490 | 3,500 | -50 | -1.4% | 65,400 |
| 2023/02/13 | 3,550 | 3,570 | 3,510 | 3,550 | -40 | -1.1% | 84,400 |
| 2023/02/10 | 3,725 | 3,725 | 3,570 | 3,590 | -145 | -3.9% | 124,800 |
| 2023/02/09 | 3,750 | 3,750 | 3,680 | 3,735 | -15 | -0.4% | 64,200 |
| 2023/02/08 | 3,690 | 3,750 | 3,610 | 3,750 | +75 | +2% | 90,000 |
| 2023/02/07 | 3,655 | 3,680 | 3,625 | 3,675 | +45 | +1.2% | 46,500 |
| 2023/02/06 | 3,600 | 3,675 | 3,580 | 3,630 | +30 | +0.8% | 70,900 |
| 2023/02/03 | 3,660 | 3,660 | 3,580 | 3,600 | -10 | -0.3% | 51,600 |
| 2023/02/02 | 3,605 | 3,660 | 3,605 | 3,610 | -20 | -0.6% | 73,600 |
| 2023/02/01 | 3,670 | 3,690 | 3,620 | 3,630 | ±0 | ±0% | 56,000 |
| 2023/01/31 | 3,645 | 3,665 | 3,555 | 3,630 | -40 | -1.1% | 112,500 |
| 2023/01/30 | 3,745 | 3,745 | 3,640 | 3,670 | -5 | -0.1% | 80,800 |
| 2023/01/27 | 3,690 | 3,790 | 3,660 | 3,675 | +15 | +0.4% | 133,200 |
| 2023/01/26 | 3,700 | 3,725 | 3,610 | 3,660 | -20 | -0.5% | 89,800 |
401～
450
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
